Repro Med Systems Stock Alpha and Beta Analysis
| KRMD Stock | USD 3.66 0.14 3.98% |
This module allows you to check different measures of market premium (i.e., alpha and beta) for all equities such as Repro Med Systems. It also helps investors analyze the systematic and unsystematic risks associated with investing in Repro Med over a specified time horizon. Remember, high Repro Med's alpha is almost always a sign of good performance; however, a high beta will depend on investors' risk tolerance level and may signal increased volatility and potential future overvaluation. Key technical indicators related to Repro Med's market risk premium analysis include:
Beta 0.0583 | Alpha 0.75 | Risk 3.53 | Sharpe Ratio 0.2 | Expected Return 0.71 |
Enterprise Value |
|
Alpha is a measure of relative performance on a risk-adjusted basis, while beta measures volatility against the benchmark. The goal is to know if an investor is being compensated for the volatility risk taken. The return on investment might be better than its reference but still not compensate for the assumption of the risk.
Repro |
Repro Med Market Premiums
Investors always prefer to have the highest possible return on investment, coupled with the lowest possible volatility. Repro Med market risk premium is the additional return an investor will receive from holding Repro Med long position in a well-diversified portfolio. The market premium is part of the Capital Asset Pricing Model (CAPM), which most analysts and investors use to calculate the acceptable rate of return on investment in Repro Med. At the center of the CAPM is the concept of risk and reward, which is usually communicated by investors using alpha and beta measures. Alpha and beta are two of the key measurements used to evaluate Repro Med's performance over market.| α | 0.75 | β | 0.06 |
Repro Med expected buy-and-hold returns
Although buy-and-hold investment strategy may not appeal to all investors, it may be used as a good measure of Repro Med's Buy-and-hold return. Our buy-and-hold chart shows how Repro Med performed over your current time horizon against a typical interest-earning bank account and a selected benchmark.Repro Med Market Price Analysis
Market price analysis indicators help investors to evaluate how Repro Med stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Repro Med shares will generate the highest return on investment. By understating and applying Repro Med stock market price indicators, traders can identify Repro Med position entry and exit signals to maximize returns.
Repro Med Return and Market Media
The median price of Repro Med for the period between Wed, Aug 28, 2024 and Tue, Nov 26, 2024 is 2.62 with a coefficient of variation of 10.9. The daily time series for the period is distributed with a sample standard deviation of 0.29, arithmetic mean of 2.68, and mean deviation of 0.21. The Stock received substential amount of media coverage during this period. Price Growth (%) |
| Timeline |
1 | Acquisition by Linda Tharby of 19681 shares of Repro Med at 2.09 subject to Rule 16b-3 | 09/20/2024 |
2 | Acquisition by Manko Joseph M. Jr. of 5454 shares of Repro Med subject to Rule 16b-3 | 09/30/2024 |
3 | Acquisition by Cascella Robert of 5454 shares of Repro Med at 2.75 subject to Rule 16b-3 | 10/01/2024 |
4 | Further weakness as KORU Medical Systems drops 10 percent this week, taking five-year losses to 38 | 10/09/2024 |
5 | LivaNova Tops Q3 Earnings and Revenue Estimates | 10/30/2024 |
6 | KORU Medical Systems Presents Data at Partnership Opportunities in Drug Delivery Conference Demonstrating Nursing Preference for Use of KORU FreedomEdge Infusio... | 10/31/2024 |
7 | Disposition of 721781 shares by Manko Joseph M. Jr. of Repro Med subject to Rule 16b-3 | 11/08/2024 |
8 | KORU Medical Systems, Inc. Announces 2024 Q3 Financial Results, Third Consecutive Quarter of Double-Digit Growth Raises Full Year 2024 Guidance | 11/13/2024 |
9 | Koru Medical Systems stock target increased, holds buy on strong quarter | 11/14/2024 |
10 | KORU Medical Systems, Inc. Q3 2024 Earnings Call Transcript | 11/15/2024 |
11 | KRMD stock touches 52-week high at 3.41 amid robust growth - Investing.com Australia | 11/21/2024 |
About Repro Med Beta and Alpha
For many years both, Alpha and Beta indicators are used by professional money managers as critical performance measurement tools across virtually all financial instruments including Repro or other stocks. Alpha measures the amount that position in Repro Med Systems has returned in comparison to a selected market index or another relevant benchmark. In other words, Alpha is the excess return on an investment relative to the performance of your selected benchmark. Beta, on the other hand, measures the relative risk of your investment.
| 2023 | 2024 (projected) | Dividend Yield | 0.002203 | 0.003082 | Price To Sales Ratio | 3.93 | 2.26 |
Repro Med Upcoming Company Events
As portrayed in its financial statements, the presentation of Repro Med's financial position is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Repro Med's leadership is honest, while the outside auditors are strict and uncompromising. Whatever the case, investors should always follow all of Repro Med's public filing events to personally review all filings and be reasonable and skeptical to interpret all of the financial statements of Repro Med. Please utilize our Beneish M Score to check the likelihood of Repro Med's management manipulating its earnings.
| 13th of March 2024 Upcoming Quarterly Report | View | |
| 2nd of May 2024 Next Financial Report | View | |
| 31st of December 2023 Next Fiscal Quarter End | View | |
| 13th of March 2024 Next Fiscal Year End | View | |
| 30th of September 2023 Last Quarter Report | View | |
| 31st of December 2022 Last Financial Announcement | View |
Build Portfolio with Repro Med
Your optimized portfolios are the building block of your wealth. We provide an intuitive interface to determine which securities in a portfolio should be removed or rebalanced to achieve better diversification, find the right mix of securities that minimizes portfolio risk for a given return, or maximize portfolio expected return for a given risk level.Build Diversified Portfolios
Align your risk with return expectations
Check out Repro Med Backtesting, Repro Med Valuation, Repro Med Correlation, Repro Med Hype Analysis, Repro Med Volatility, Repro Med History and analyze Repro Med Performance. You can also try the Piotroski F Score module to get Piotroski F Score based on the binary analysis strategy of nine different fundamentals.
Repro Med technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.